abstract |
The present invention is directed to methods, compositions and kits for the treatment of cancer, such as hepatocellular carcinoma. In some embodiments, the present invention discloses the use of small molecule compounds of general formula (I)-(XXVI) disclosed herein to inhibit the transcription factor late SV40 factor (LSF) for the treatment of cancers such as HCC. |